Kiyomi Morita - Concepedia

Author

Kiyomi Morita

The University of Texas MD Anderson Cancer Center ORCID

Also Known As

K Morita, Kiyomi Morita, Morita Kiyomi

Publications

1.3K

Citations

H-Index

Concepts

All Affiliations

The University of Texas MD Anderson Cancer Center Hirosaki University The University of Texas Health Science Center at Houston The University of Tokyo ETH Zurich

About

Kiyomi Morita is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, bioinformatics, and genomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	4	4	216
2	Engineering	2	2	187
3	Health Sciences	1	1	16
4	Public Health	1	1	13
5	Biostatistics	1	1	13

Kiyomi Morita

Publications

1.2K

Citations

H-Index

Page 1

	Year	Citations
Clonal evolution of acute myeloid leukemia revealed by high-throughput single-cell genomics Kiyomi Morita, Feng Wang, Katharina Jahn, Nature Communications	2020	364
Clearance of Somatic Mutations at Remission and the Risk of Relapse in Acute Myeloid Leukemia Kiyomi Morita, Hagop M. Kantarjian, Feng Wang, Journal of Clinical Oncology	2018	182
Integrative genomic analysis of adult mixed phenotype acute leukemia delineates lineage associated molecular subtypes Koichi Takahashi, Feng Wang, Kiyomi Morita, Nature Communications EngineeringMixed-phenotype Acute LeukemiaGeneticsIntegrative Genomic AnalysisEpigenetic Change	2018	120
Leukemia stemness and co-occurring mutations drive resistance to IDH inhibitors in acute myeloid leukemia Feng Wang, Kiyomi Morita, Courtney D. DiNardo, Nature Communications	2021	109
Outcome of T‐cell acute lymphoblastic leukemia/lymphoma: Focus on <scp>near‐ETP</scp> phenotype and differential impact of nelarabine Kiyomi Morita, Nitin Jain, Hagop M. Kantarjian, American Journal of Hematology	2021	82
Clonal Evolution of Acute Myeloid Leukemia Revealed by High-Throughput Single-Cell Genomics Kiyomi Morita, Feng Wang, Katharina Jahn, EngineeringMixed-phenotype Acute LeukemiaGeneticsGenomicsTumor Biology	2020	67
Clonal dynamics and clinical implications of postremission clonal hematopoiesis in acute myeloid leukemia Tomoyuki Tanaka, Kiyomi Morita, Sanam Loghavi, Blood	2021	41
PRDM16s transforms megakaryocyte-erythroid progenitors into myeloid leukemia–initiating cells Tianyuan Hu, Kiyomi Morita, Matthew C. Hill, Blood	2019	28
The prevalence of gene mutations in homologous recombination repair pathways in Japanese patients with metastatic castration‐resistant prostate cancer in real‐world clinical practice: The multi‐institutional observational <scp>ZENSHIN</scp> study Hiroji Uemura, Mototsugu Oya, Toshiyuki Kamoto, Cancer Medicine	2022	28
A Phase II Study of Double Immune Checkpoint Inhibitor Blockade with Nivolumab and Ipilimumab with or without Azacitidine in Patients with Myelodysplastic Syndrome (MDS) Kiyomi Morita, Hagop M. Kantarjian, Guillermo Montalban‐Bravo, Blood	2020	27

Page 1